|
Study sites
|
National indigenous PHC‡
|
DAHS 2008-09¶
|
---|
|
DAHS
|
ACCHS-2
|
ACCHS-3
|
ACCHS-4
|
All ACCHSs
|
---|
Median annual clinical outcome measures
|
HbA1c (%)
|
8
|
8.5
|
8.7†
|
8.1
|
8.2
|
8.8-9.2
|
8.0
|
BP systolic (mmHg)
|
127
|
130
|
125
|
135*
|
128
|
126-133
|
120
|
BP diastolic (mmHg)
|
77
|
80
|
80†
|
83*
|
78
|
77-80
|
75
|
Total cholesterol (mmol/L)
|
4.4
|
4.6
|
4.8*
|
4.2
|
4.5
|
4.7-4.8
|
4.5
|
ACR
|
8.7
|
15.6
|
44.1*
|
3.6
|
15.6
|
5.9-7.1
| |
Proportion of study population with median values that met targets
| |
HbA1c ≤7%
|
31%
|
25%
|
16%*
|
17%
|
26%
|
16-32
|
34%
|
BP ≤130/80**
|
53%
|
47%
|
48%
|
19%*
|
38%
|
28-64
|
69%
|
Total cholesterol ≤4 mmol/L
|
39%
|
42%
|
19%*
|
27%
|
34%
|
29
|
25%
|
ACR <3.6 mg/mmol
|
38%
|
29%
|
16%*
|
44%
|
30%
|
38
| |
- DAHS = Derby Aboriginal Health Service. PHC = primary health care. HbA1c = glycated haemoglobin. BP = blood pressure. ACR = albumin creatinine ratio.
-
‡Australian Aboriginal and Torres Strait Islander patients treated in PHC settings [29, 30, 34–37].
-
¶Final year of the “DAHS diabetes study” [28].
- *Statistically significant difference (P ≤ 0.05) when compared with ACCHS 1.
-
†Approached statistical significance when compared with DAHS (P = 0.05).
-
**At least half of each participant’s recorded measurements met the recommended target for both systolic and diastolic BP.